Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Swissray Intl. Inc. (SRMI) -- Ignore unavailable to you. Want to Upgrade?

To: SIer formerly known as Joe B. who wrote (400)	4/16/1998 12:19:00 PM
From: Judy Helkowski	Read Replies (2) \| Respond to of 763

Joe, If you know of another company with FDA approval for any specific use, please post. I may be wrong, but I don't think there are any at this time. The reason I say this is that I recently had a conversation with a broker from an investment firm in Boston called Leerink, Swann and Company. They specialize in medical stocks. We were discussing another stock waiting for FDA approval for their digital mammography unit which his company is recommending. He was telling me how they would be the first to get FDA approval (expected this summer) and would be at least 6 months ahead of the competition. I told him about Swissray and how they already had FDA approval for their complete system and he was quite surprised to say the least. He of course had never heard of Swissray. He said he would have some of the doctors who do their evaluating check into Swissray and its products and get back to me. I haven't heard back from him yet. That was about a week ago. Obviously the fact that he never heard of Swissray is part of the problem. They need to become more well-known and take advantage of the lead they have at the moment. Maybe they need to place one of their units in the Cleveland Clinic or Mayo Clinic for free on a trial basis just to get the exposure. If it works as well as they say, it would certainly enhance their reputation. Judy H.